Lionel P Nelson, MD
Otolaryngology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 34
- 9 carriers
- Offices
- 3
Offices
3 locations · Bass Medical Group · 292 clinicians in this group
Looking this up.
Plans that list them
34 plans · 9 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nelson’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
34 of 34 plans
| Advantage Care (HMO) | Align Senior Care | Listed | Oct 1, 2026 |
| Premier Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Senior Care (HMO I-SNP) | Align Senior Care | Listed | Oct 1, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G19842 · Current
Licensed to practise in California · since 1971 · expires 2028-02-29 · Yale University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Silicon Valley Surgery Center, LPAmbulatory Surgery Center · Campbell, CA1.27% owner since 2012 · accredited by AAAHCAccreditation Renewed4 inspections, 1 with deficiencies · last 2024-09-16
- Silicon Valley Surgery Center, LP - BascomAmbulatory Surgery Center · Campbell, CA1.27% owner since 2012 · accredited by AAAHCAccreditation RenewedNo inspections published
Original Medicare doctor bills
$81,001
Medicare paid this office $81,001 for 335 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 122 | $18,388 | $113 |
| Short return visit (20+ min) | 117 | $12,105 | $80 |
| Long return visit (40+ min) | 57 | $9,822 | $166 |
| Diagnostic exam of voice box using a flexible endoscope | 65 | $8,956 | $128 |
| New patient visit (30+ min) | 90 | $8,444 | $94 |
See all 7 services
| Return visit (30+ min) | 122 | $18,388 | $113 |
| Short return visit (20+ min) | 117 | $12,105 | $80 |
| Long return visit (40+ min) | 57 | $9,822 | $166 |
| Diagnostic exam of voice box using a flexible endoscope | 65 | $8,956 | $128 |
| New patient visit (30+ min) | 90 | $8,444 | $94 |
| New patient visit (45+ min) | 51 | $6,814 | $134 |
| Diagnostic exam of nasal passages using an endoscope | 35 | $6,812 | $184 |
Who their Medicare patients are
335 Original Medicare patients in 2024. Average age 77 · Women 59% · Also on Medicaid 4% · Health risk score 0.97. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 71% · Coronary heart disease 31% · Diabetes 25% · Atrial fibrillation 20% · Chronic kidney disease 19% · Cancer 17% · Depression 15% · Heart failure 13% · Stroke 12% · COPD 10% · Dementia 4%.
The office billed $315,751, Medicare allowed $110,178 and paid $81,001; for 675 services of 22 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 335 | 675 | 77 | 0.97 | $315,751 | $81,001 |
| 2023 | 386 | 769 | 77 | 1.04 | $339,188 | $89,864 |
| 2022 | 417 | 894 | 78 | 1.02 | $403,478 | $105,215 |
| 2021 | 334 | 750 | 78 | 1.03 | $343,707 | $96,250 |
| 2020 | 178 | 323 | 76 | 1.14 | $137,820 | $32,286 |
| 2019 | 532 | 1,316 | 77 | 1.13 | $507,922 | $138,685 |
| 2018 | 571 | 1,448 | 76 | 1.13 | $529,153 | $138,071 |
| 2017 | 575 | 1,494 | 77 | 1.06 | $586,138 | $149,694 |
| 2016 | 628 | 1,305 | 77 | 1.13 | $324,817 | $136,903 |
| 2015 | 618 | 1,213 | 76 | 1.12 | $386,000 | $144,510 |
| 2014 | 622 | 1,231 | 76 | 1.01 | $396,020 | $144,669 |
| 2013 | 511 | 992 | 75 | 1.08 | $270,030 | $113,932 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Return visit (30+ min) | 141 | $22,496 | $116 |
| Short return visit (20+ min) | 141 | $13,616 | $79 |
| Diagnostic exam of nasal passages using an endoscope | 51 | $11,694 | $195 |
| New patient visit (30+ min) | 101 | $9,965 | $99 |
| New patient visit (45+ min) | 72 | $9,947 | $138 |
| Long return visit (40+ min) | 44 | $7,214 | $157 |
| Diagnostic exam of voice box using a flexible endoscope | 43 | $6,355 | $130 |
| Simple control of nose bleed | 11 | $2,620 | $175 |
| Short return visit | 21 | $1,210 | $48 |
2022: 10 services
| Return visit (30+ min) | 170 | $27,107 | $113 |
| Diagnostic exam of nasal passages using an endoscope | 55 | $15,129 | $192 |
| Short return visit (20+ min) | 145 | $13,841 | $77 |
| New patient visit (30+ min) | 116 | $10,616 | $92 |
| New patient visit (45+ min) | 75 | $10,389 | $139 |
| Diagnostic exam of voice box using a flexible endoscope | 61 | $8,459 | $128 |
| Long return visit (40+ min) | 47 | $7,824 | $160 |
| Simple control of nose bleed | 30 | $5,237 | $145 |
| New patient visit (60+ min) | 12 | $2,507 | $209 |
| Short return visit | 12 | $608 | $51 |
2021: 9 services
| Return visit (30+ min) | 131 | $23,372 | $124 |
| Short return visit (20+ min) | 135 | $14,901 | $86 |
| Diagnostic exam of nasal passages using an endoscope | 55 | $14,840 | $206 |
| New patient visit (45+ min) | 75 | $11,377 | $152 |
| Diagnostic exam of voice box using a flexible endoscope | 55 | $8,253 | $131 |
| New patient visit (30+ min) | 80 | $8,230 | $103 |
| Simple control of nose bleed | 14 | $2,926 | $163 |
| Long return visit (40+ min) | 15 | $2,527 | $168 |
| Short return visit | 18 | $1,125 | $56 |
2020: 6 services
| Return visit (30+ min) | 88 | $10,006 | $87 |
| Diagnostic exam of nasal passages using an endoscope | 25 | $5,151 | $178 |
| New patient visit (30+ min) | 41 | $3,374 | $82 |
| Short return visit (20+ min) | 47 | $2,693 | $52 |
| New patient visit (45+ min) | 18 | $2,269 | $126 |
| Diagnostic exam of voice box using a flexible endoscope | 20 | $2,182 | $109 |
2019: 12 services
| Return visit (30+ min) | 210 | $32,184 | $101 |
| Diagnostic exam of nasal passages using an endoscope | 104 | $26,918 | $198 |
| Short return visit (20+ min) | 222 | $20,794 | $67 |
| New patient visit (30+ min) | 178 | $17,071 | $96 |
| New patient visit (45+ min) | 89 | $12,506 | $141 |
| Diagnostic exam of voice box using a flexible endoscope | 76 | $9,453 | $107 |
| Simple control of nose bleed | 28 | $4,568 | $134 |
| Removal of impacted ear wax | 42 | $1,925 | $44 |
| Long return visit (40+ min) | 13 | $1,662 | $128 |
| New patient visit (15+ min) | 20 | $1,257 | $63 |
| Exam of ear using a microscope | 18 | $458 | $25 |
| Short return visit | 11 | $445 | $40 |
2018: 11 services
| Return visit (30+ min) | 245 | $32,202 | $94 |
| Diagnostic exam of nasal passages using an endoscope | 95 | $22,971 | $198 |
| Short return visit (20+ min) | 200 | $16,908 | $63 |
| New patient visit (30+ min) | 177 | $15,736 | $89 |
| New patient visit (45+ min) | 104 | $14,278 | $137 |
| Diagnostic exam of voice box using a flexible endoscope | 121 | $13,385 | $99 |
| Simple control of nose bleed | 33 | $4,855 | $116 |
| Exam of ear using a microscope | 126 | $4,545 | $28 |
| Long return visit (40+ min) | 17 | $1,831 | $108 |
| New patient visit (15+ min) | 18 | $983 | $55 |
| Repositioning exercises of head for treatment of dizziness, each day | 11 | $429 | $39 |
2017: 11 services
| Return visit (30+ min) | 274 | $36,567 | $94 |
| Diagnostic exam of nasal passages using an endoscope | 94 | $21,824 | $191 |
| New patient visit (45+ min) | 150 | $19,867 | $132 |
| Diagnostic exam of voice box using a flexible endoscope | 122 | $13,665 | $100 |
| New patient visit (30+ min) | 154 | $13,216 | $86 |
| Short return visit (20+ min) | 145 | $10,908 | $59 |
| Exam of ear using a microscope | 139 | $4,992 | $28 |
| Long return visit (40+ min) | 36 | $4,727 | $124 |
| Simple control of nose bleed | 20 | $1,749 | $76 |
| New patient visit (15+ min) | 14 | $759 | $54 |
| Short return visit | 11 | $409 | $34 |
2016: 11 services
| Return visit (30+ min) | 214 | $27,837 | $93 |
| New patient visit (45+ min) | 181 | $25,155 | $139 |
| Diagnostic exam of nasal passages using an endoscope | 74 | $19,771 | $208 |
| Diagnostic exam of voice box using a flexible endoscope | 123 | $14,898 | $109 |
| Short return visit (20+ min) | 185 | $13,928 | $64 |
| New patient visit (30+ min) | 136 | $12,163 | $89 |
| Simple control of nose bleed | 26 | $3,073 | $83 |
| Exam of ear using a microscope | 70 | $2,577 | $30 |
| Long return visit (40+ min) | 13 | $1,827 | $130 |
| Short return visit | 20 | $814 | $41 |
| New patient visit (15+ min) | 11 | $756 | $69 |
2015: 9 services
| Return visit (30+ min) | 225 | $30,624 | $95 |
| New patient visit (45+ min) | 186 | $27,064 | $146 |
| Diagnostic exam of nasal passages using an endoscope | 65 | $18,608 | $209 |
| New patient visit (30+ min) | 143 | $13,213 | $92 |
| Diagnostic exam of voice box using a flexible endoscope | 106 | $12,941 | $110 |
| Short return visit (20+ min) | 147 | $11,869 | $62 |
| Simple control of nose bleed | 31 | $3,398 | $89 |
| New patient visit (15+ min) | 18 | $1,120 | $62 |
| Short return visit | 13 | $466 | $36 |
2014: 11 services
| Return visit (30+ min) | 186 | $22,475 | $95 |
| New patient visit (45+ min) | 150 | $21,833 | $146 |
| New patient visit (30+ min) | 184 | $16,792 | $91 |
| Diagnostic exam of nasal passages using an endoscope | 54 | $14,004 | $212 |
| Diagnostic exam of voice box using a flexible endoscope | 119 | $13,729 | $110 |
| Short return visit (20+ min) | 168 | $12,533 | $62 |
| Simple control of nose bleed | 30 | $3,497 | $90 |
| Long return visit (40+ min) | 25 | $2,940 | $113 |
| Removal of impacted ear wax | 45 | $2,238 | $42 |
| New patient visit (15+ min) | 33 | $2,167 | $66 |
| Short return visit | 12 | $540 | $42 |
2013: 11 services
| Return visit (30+ min) | 164 | $19,318 | $95 |
| New patient visit (45+ min) | 113 | $16,330 | $145 |
| Diagnostic exam of voice box using a flexible endoscope | 93 | $11,622 | $114 |
| Short return visit (20+ min) | 141 | $11,029 | $64 |
| New patient visit (30+ min) | 110 | $10,151 | $92 |
| Diagnostic exam of nasal passages using an endoscope | 24 | $7,472 | $220 |
| Long return visit (40+ min) | 35 | $5,342 | $119 |
| Simple control of nose bleed | 26 | $2,590 | $86 |
| New patient visit (15+ min) | 37 | $2,212 | $60 |
| Short return visit | 34 | $1,303 | $34 |
| Removal of impacted ear wax | 14 | $748 | $50 |
Drugs they prescribed that Part D paid
$6,941
Pharmacies billed $6,941 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 274) in 2024. At or below the middle of the specialty; the typical otolaryngology clinician is at 4%.
268 generic and fewer than 11 brand-name prescriptions · $6,941 in drug cost · 22 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ipratropium | 71 | $1,974 | $28 |
| Pilocarpine | 19 | $990 | $52 |
| Fluocinolone Acetonide Oil | 17 | $520 | $31 |
| Mometasone Furoate | 24 | $172 | $7 |
| Montelukast | 16 | $157 | $10 |
See all 7 drugs
| Ipratropium | 71 | $1,974 | $28 |
| Pilocarpine | 19 | $990 | $52 |
| Fluocinolone Acetonide Oil | 17 | $520 | $31 |
| Mometasone Furoate | 24 | $172 | $7 |
| Montelukast | 16 | $157 | $10 |
| Methylprednisolone | 22 | $141 | $6 |
| Mupirocin | 11 | $44 | $4 |
Year by year
| 2024 | 274 | 130 | 0% (0) | None | $6,941 |
| 2023 | 220 | 101 | 0% (0) | None | $6,502 |
| 2022 | 225 | 117 | 0% (0) | None | $7,857 |
| 2021 | 197 | 93 | 0% (0) | None | $5,434 |
| 2020 | 167 | 69 | 0% (0) | None | $4,474 |
| 2019 | 365 | 179 | 0% (0) | 3% | $10,417 |
| 2018 | 308 | 145 | None | None | $10,535 |
| 2017 | 351 | 163 | 4% (13) | None | $9,419 |
| 2016 | 432 | 185 | 3% (14) | None | $9,395 |
| 2015 | 488 | 190 | 3% (13) | 5% | $10,901 |
| 2014 | 481 | 191 | 4% (18) | 7% | $12,277 |
| 2013 | 446 | 166 | 5% (21) | 13% | $18,888 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Ipratropium | 47 | $1,494 | $32 |
| Azelastine | 12 | $914 | $76 |
| Fluocinolone Acetonide Oil | 15 | $751 | $50 |
| Montelukast | 22 | $535 | $24 |
| Methylprednisolone | 30 | $347 | $12 |
| Mometasone Furoate | 16 | $263 | $16 |
| Amoxicillin-Clavulanate Potass | 12 | $192 | $16 |
2022: 6 drugs
| Ipratropium | 60 | $2,563 | $43 |
| Fluocinolone Acetonide Oil | 11 | $907 | $82 |
| Amoxicillin-Clavulanate Potass | 16 | $239 | $15 |
| Mometasone Furoate | 18 | $199 | $11 |
| Methylprednisolone | 18 | $190 | $11 |
| Clotrimazole-Betamethasone | 12 | $121 | $10 |
2021: 5 drugs
| Ipratropium | 65 | $2,508 | $39 |
| Mometasone Furoate | 22 | $278 | $13 |
| Montelukast | 12 | $181 | $15 |
| Amoxicillin-Clavulanate Potass | 14 | $176 | $13 |
| Methylprednisolone | 18 | $137 | $8 |
2020: 4 drugs
| Ipratropium | 49 | $2,211 | $45 |
| Montelukast | 28 | $410 | $15 |
| Omeprazole | 15 | $201 | $13 |
| Methylprednisolone | 13 | $134 | $10 |
2019: 8 drugs
| Ipratropium | 65 | $3,331 | $51 |
| Neomycin-Polymyxin-Hc | 13 | $787 | $61 |
| Montelukast | 43 | $631 | $15 |
| Amoxicillin-Clavulanate Potass | 32 | $413 | $13 |
| Methylprednisolone | 43 | $408 | $9 |
| Mometasone Furoate | 22 | $367 | $17 |
| Omeprazole | 26 | $361 | $14 |
| Prednisone | 24 | $109 | $5 |
2018: 8 drugs
| Ipratropium | 61 | $3,072 | $50 |
| Montelukast | 27 | $428 | $16 |
| Azelastine | 13 | $428 | $33 |
| Methylprednisolone | 28 | $337 | $12 |
| Amoxicillin-Clavulanate Potass | 22 | $284 | $13 |
| Mometasone Furoate | 19 | $281 | $15 |
| Omeprazole | 19 | $232 | $12 |
| Prednisone | 19 | $81 | $4 |
2017: 9 drugs
| Ipratropium | 50 | $1,919 | $38 |
| Neomycin-Polymyxin-Hc | 22 | $1,147 | $52 |
| Fluticasone Propionate | 26 | $556 | $21 |
| Amoxicillin-Clavulanate Potass | 33 | $496 | $15 |
| Methylprednisolone | 29 | $397 | $14 |
| Montelukast | 24 | $323 | $13 |
| Mometasone Furoate | 19 | $175 | $9 |
| Prednisone | 31 | $152 | $5 |
| Hydrocodone-Acetaminophen | 13 | $83 | $6 |
2016: 11 drugs
| Ipratropium | 44 | $1,087 | $25 |
| Fluticasone Propionate | 87 | $958 | $11 |
| Amoxicillin-Clavulanate Potass | 43 | $642 | $15 |
| Neomycin-Polymyxin-Hc | 13 | $623 | $48 |
| Methylprednisolone | 42 | $599 | $14 |
| Cephalexin | 20 | $417 | $21 |
| Mometasone Furoate | 27 | $315 | $12 |
| Montelukast | 18 | $244 | $14 |
| Omeprazole | 12 | $226 | $19 |
| Hydrocodone-Acetaminophen | 13 | $121 | $9 |
| Prednisone | 25 | $98 | $4 |
2015: 12 drugs
| Fluticasone Propionate | 127 | $1,399 | $11 |
| Montelukast | 34 | $1,319 | $39 |
| Ipratropium | 38 | $869 | $23 |
| Methylprednisolone | 41 | $739 | $18 |
| Neomycin-Polymyxin-Hc | 22 | $451 | $20 |
| Amoxicillin-Clavulanate Potass | 32 | $434 | $14 |
| Levofloxacin | 20 | $391 | $20 |
| Omeprazole | 20 | $209 | $10 |
| Hydrocodone-Acetaminophen | 11 | $121 | $11 |
| Mometasone Furoate | 14 | $86 | $6 |
| Prednisone | 15 | $81 | $5 |
| Cephalexin | 13 | $70 | $5 |
2014: 10 drugs
| Fluticasone Propionate | 149 | $2,270 | $15 |
| Montelukast | 38 | $1,823 | $48 |
| Ipratropium | 30 | $706 | $24 |
| Azelastine | 11 | $590 | $54 |
| Amox Tr-Potassium Clavulanate | 30 | $581 | $19 |
| Methylprednisolone | 29 | $579 | $20 |
| Hydrocodone-Acetaminophen | 17 | $230 | $14 |
| Prednisone | 27 | $139 | $5 |
| Mometasone Furoate | 11 | $114 | $10 |
| Cephalexin | 15 | $93 | $6 |
2013: 11 drugs
| Fluticasone Propionate | 159 | $4,317 | $27 |
| Montelukast | 23 | $2,431 | $106 |
| Nasonex | 12 | $1,932 | $161 |
| Triamcinolone Acetonide | 13 | $667 | $51 |
| Azelastine | 11 | $643 | $58 |
| Amox Tr-Potassium Clavulanate | 24 | $527 | $22 |
| Ipratropium | 14 | $433 | $31 |
| Methylprednisolone | 15 | $346 | $23 |
| Neomycin-Polymyxin-Hc | 14 | $295 | $21 |
| Hydrocodone-Acetaminophen | 19 | $193 | $10 |
| Prednisone | 16 | $53 | $3 |
Money from drug and device companies
$201 in 2024
| 2024 | 1 | 1 | None | $201 |
| 2019 | 2 | 2 | None | $55 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Neurent Medical | Neuromark Device | $201 | 1 payment
|
See the published payment
| Neurent Medical | Meals · 2024-03-22 | Neuromark Device | $201 |
See earlier years (2019)
2019: $55
| Smith+Nephew | Coblation Wands | $44 | 1 payment
|
| Philips Electronics North America | Premium Gum Care | $12 | 1 payment
|
Checkups this office reported
17 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 87.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Appropriate Treatment for Upper Respiratory Infection (URI)As Medicare defines this measure | 96% | 46 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 88%That's most of the people this applied to. | 460 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 41%That's less than half. | 111 |
| Bone-density scans that were not neededYounger women who got a bone scan without a medical reason | 0%That's few of the people this applied to. Better on this measure. | 103 |
| Breast cancer screeningEligible women who got a mammogram | 24%That's few of the people this applied to. | 303 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 16%That's few of the people this applied to. | 340 |
| Checked for fall riskOlder patients screened for fall risk | 4%That's few of the people this applied to. | 543 |
| Colon cancer screeningEligible adults who got a colon cancer test | 13%That's few of the people this applied to. | 643 |
See the other 9 measures
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 2%That's few of the people this applied to. | 1,215 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 14%That's few of the people this applied to. | 29 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 66%That's more than half. Worse on this measure. | 29 |
| HIV screeningEligible patients who were screened for HIV | 12%That's few of the people this applied to. | 749 |
| Medications listed in the chartVisits where the current medication list was documented | 97%That's most of the people this applied to. | 1,936 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 97%That's most of the people this applied to. | 344 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 98%That's most of the people this applied to. | 150 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 75%That's most of the people this applied to. | 129 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 45%That's less than half. | 1,240 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Improved the patient portal
- Lets patients read their visit notes
- Shows lab and imaging costs when ordering tests
- Uses standard treatment protocols
- Exempt from electronic case reporting
- Exempt from immunization registry reporting
- Exempt from query of the prescription drug monitoring program (pdmp)
Professional record
- NPI
- 1902838063
- Licence
- CA G19842California G19842: Current · expires 2028-02-29
- Trained
- Yale University School of Medicine, 1969
- Group
- Bass Medical Group
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G198420
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 2577 Samaritan Dr Ste 765, San Jose, CA, 95124
- NPI first listed
- 2006-07-07
- NPI last updated
- 2025-02-28
- NPI record certified
- 2025-02-28
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2505 Samaritan Dr #510, San Jose, CA, 95124